Diagnosis and treatment of alcoholic liver disease and its complications

Alcohol Research and Health

Volumn 27, Issue 3, 2003, Pages 247-256

  Marsano, Luis S ^a,b   Mendez, Christian ^b   Hill, Daniell ^a,b   Barve, Shirish ^a,b   McClain, Craig J ^a,b  

^a Department of Internal Medicine ^*  (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

Alcoholic liver disorder; Alternative medical treatment; Ascites; Colchicines; Corticosterone; Diagnosis; Disease complication; Drug therapy; Lifestyle; Nutritional deficiency; Peritonitis; Propylthiouracil; S adenosylmethionine; Treatment method; Vitamin therapy

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFOTAXIME; COLCHICINE; CORTICOSTEROID; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; NORADRENALIN; OCTREOTIDE; ORNIPRESSIN; PENTOXIFYLLINE; PREDNISONE; PROPYLTHIOURACIL; S ADENOSYLMETHIONINE; SILYMARIN; TERLIPRESSIN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ASCITES; BACTERIAL PERITONITIS; CIGARETTE SMOKING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIET SUPPLEMENTATION; DIET THERAPY; ESOPHAGUS VARICES; HEPATORENAL SYNDROME; HUMAN; LABORATORY TEST; LIFESTYLE; MORTALITY; OBESITY; QUALITY OF LIFE; REVIEW; BACTERIAL INFECTION; METHODOLOGY;

ASCITES; BACTERIAL INFECTIONS; HUMANS; LIVER DISEASES, ALCOHOLIC; NUTRITION THERAPY;

EID: 16544384183     PISSN: 0090838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. AKRIVIADIS, E.; BOTLA, R.; BRIGGS, W.; ET AL. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial. Gastroenterology 119(6):1637-1648, 2000.
2. ANDY, S.Y., AND KE-QIN, H. Management of ascites. Clinics in Liver Disease 5:541-568, 2001.
3. ANGELI, P.; VOLPIN, R.; GERUNDA, G.; ET AL. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29(6):1690-1697, 1999.
4. BIRD, G.L., AND WILLIAMS, R. Factors determining cirrhosis in alcoholic liver disease. Molecular Aspects of Medicine 10(2):97-105, 1988.
5. CABRE, E., RODRIGUEZ-IGLESIAS, P.; CABALLERIA, J.; ET AL. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial. Hepatology 32(1):36-42, 2000.
6. CARITHERS, R.L., JR.; HERLONG, H.F.; DIEHL, A.M.; ET AL. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Annals of Internal Medicine 110(9):685-690, 1989.
7. CHEDID, A.; MENDENHALL, C.L.; GARTSIDE, P.; ET AL. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. American Journal of Gastroenterology 86(2):210-216, 1991.
8. CORRAO, G.; LEPORE, A.R.; TORCHIO, P.; ET AL. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. European Journal of Epidemiology 10(6):657-664, 1994.
9. CORTEZ-PINTO, H.; ALEXANDRINO, P.; CAMILO, M.P.; ET AL. Lack of effect of colchicine in alcoholic cirrhosis: Final results of a double blind randomized trial. European Journal of Gastroenterology and Hepatology 14(4):377-381, 2002.
10. D'AMICO, G.; PAGLIARO, L.; AND BOSCH, J. Pharmacological treatment of portal hypertension: An evidence-based approach. Seminars in Liver Disease 19 (4):475-505, 1999.
11. DUVOUX, C.; ZANDITENAS, D.; HÉZODE, C.; ET AL. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study. Hepatology 36(2):374-380, 2002.
12. GARCIA, N., JR., AND SANYAL, A.J. Portal hypertension. Clinics in Liver Disease 5(2):509-540, 2001.
13. GARCIA-TSAO, G. Spontaneous bacterial peritonitis. Gastroenterology Clinics of North America 21(1):257-275, 1992.
14. GARCIA-TSAO, G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120(3):726-748, 2001.
15. GINES, A.; ESCORSELL, A.; GINES, P.; ET AL. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105(1):229-236, 1993.
16. GINES, P.; ORTEGA, R.; URIZ, J.; ET AL. Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A Phase II Study. Hepatology 34:186A, 2001.
17. GUEVARA, M.; GINES, P.; FERNANDEZ-ESPARRACH, G.; ET AL. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27(1):35-41, 1998a.
18. GUEVARA, M.; GINES, P.; BANDI, J.C.; ET AL. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems. Hepatology 28(2):416-422, 1998b.
19. HIRSCH, S.; BUNOUT, D.; DE LA MAZA, P.; ET AL. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN: Journal of Parenteral and Enteral Nutrition 17(2):119-124, 1993.
20. HIRSCH, S.; DE LA MAZA, M.P.; GATTAS, V.; ET AL. Nutritional support in alcoholic cirrhotic patients improves host defenses. Journal of the American College of Nutrition 18(5):434-441, 1999.
21. HOLT, S.; GOODIER, D.; MARLEY, R.; ET AL. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353(9149):294-295, 1999.
22. KEARNS, P.J.; YOUNG, H.; GARCIA, H.; ET AL. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 102(1):200-205, 1992.
23. KERSHENOBICH, D.; VARGAS, F.; GARCIA-TSAO, G.; ET AL. Colchicine in the treatment of cirrhosis of the liver. New England Journal of Medicine 318(26):1709-1713, 1988.
24. KLATSKY, A.L., AND ARMSTRONG, M.A. Alcohol, smoking, coffee, and cirrhosis. American Journal of Epidemiology 136(10):1248-1257, 1992.
25. LITTEN, R.Z.; ALLEN, J.P.; AND FERTIG, J.B. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption. Alcoholism: Clinical and Experimental Research 19(6):1541-1546, 1995.
26. MADDREY, W.C.; BOITNOTT, J.K.; BEDINE, M.S.; ET AL. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75(2):193-199, 1978.
27. MATHURIN, P.; MENDENHALL, C.L.; CARITHERS, R.L., JR.; ET AL. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. Journal of Hepatology 36(4):480-487, 2002.
28. MCCLAIN, C.; HILL, D.; SCHMIDT, J.; ET AL. Cytokines and alcoholic liver disease. Seminars in Liver Disease 13(2):170-182, 1993.
29. MENDENHALL, C.L.; ANDERSON, S.; GARCIA-PONT, P.; ET AL. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. New England Journal of Medicine 311(23):1464-1470, 1984.
30. MENDENHALL, C.; ROSELLE, G.A.; GARTSIDE, P.; ET AL. Relationship of protein calorie malnutrition to alcoholic liver disease: A reexamination of data from two Veterans Administration Cooperative Studies. Alcoholism: Clinical and Experimental Research 19(3):635-641, 1995.
31. MERKEL, C.; MARCHESINI, G.; FABBRI, A.; ET AL. The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death. Hepatology 24(4):820-823, 1996.
32. MITZNER, S.R.; STANGE, J.; KLAMMT, S.; ET AL. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transplantation 6(3):277-286, 2000.
33. MOREAU, R.; DURAND, F.; POYNARD, T.; ET AL. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology 122(4):923-930, 2002.
34. MORGAN, T.; NEMCHAUSKY, B.; SCHIFF, E.; ET AL. Colchicine does not prolong life in patients with advanced alcoholic cirrhosis: Results of a prospective, randomized, placebo-controlled, multicenter VA trial (Csp 352). Gastroenterology 122(Suppl.):641A, 2002.
35. NILSSEN, O.; HUSEBY, N.E.; HOYER, G.; ET AL. New alcohol markers - how useful are they in population studies: The Svalbard Study 1988-89. Alcoholism: Clinical and Experimental Research 16(1):82-86, 1992.
36. O'GRADY, J.; LAKE, J.; AND HOWDLE, P.D. Comprehensive Clinical Hepatology. Orlando, FL: Mosby, 2000.
37. ORREGO, H.; BLAKE, J.E.; BLENDIS, L.M.; ET AL. Long-term treatment of alcoholic liver disease with propylthiouracil. New England Journal of Medicine 317(23):1421-1427, 1987.
38. PARES, A.; CABALLERIA, J.; BRUGUERA, M.; ET AL. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. Journal of Hepatology 2(1):33-42, 1986.
39. PATEK, A.J.; POST, J.; AND RALNOFF, O.D. Dietary treatment of cirrhosis of the liver. JAMA: Journal of the American Medical Association 139:543-549, 1948.
40. PESSIONE, F.; RAMOND, M.J.; NJAPOUM, C.; ET AL. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34(1):121-125, 2001.
41. POWELL, W.J., JR., AND KLATSKIN, G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. American Journal of Medicine 44(3):406-420, 1968.
42. RAMBALDI, A., AND GLUUD, C. Propylthiouracil for alcoholic liver disease. Cochrane Database System Review (2)CD002800, 2002.
43. RAYNARD, B.; BALLAN, A.; FALLIK, D.; ET AL. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35(3):635-638, 2002.
44. RUNYON, B.A. Treatment of patients with cirrhosis and ascites. Seminars in Liver Disease 17(3):249-260, 1997.
45. RUNYON, B.A. Management of adult patients with ascites caused by cirrhosis. Hepatology 27(1):264-272, 1998.
46. SORT, P.; NAVASA, M.; ARROYO, V.; ET AL. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. New England Journal of Medicine 341(6):403-409, 1999.
47. U.S. Department of Health and Human Services (USDHHS). 10th Special Report to the U.S. Congress on Alcohol and Health: Highlights from the Current Research. Rockville, MD: DHHS, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 2000.